Prescription of Sulphonylureas among Patients with Type 2 Diabetes Mellitus in Italy: Results from the Retrospective, Observational Multicentre Cross-Sectional SUSCIPE (Sulphonyl_UreaS_Correct_Internal_Prescription_Evaluation) Study-Reference-Cited by-同舟云学术

Prescription of Sulphonylureas among Patients with Type 2 Diabetes Mellitus in Italy: Results from the Retrospective, Observational Multicentre Cross-Sectional SUSCIPE (Sulphonyl_UreaS_Correct_Internal_Prescription_Evaluation) Study

Published:2020-07-30 Issue:9 Volume:11 Page:2105-2119
ISSN:1869-6953
Container-title:Diabetes Therapy
language:en
Short-container-title:Diabetes Ther

Author:

Giorda Carlo Bruno^ORCID,Orsi Emanuela,De Cosmo Salvatore,Bossi Antonio Carlo,Guerzoni Catia,Cercone Stefania,Gilio Barbara,Cavalot Franco

Funder

MSD Italy

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://link.springer.com/content/pdf/10.1007/s13300-020-00871-5.pdf

Reference43 articles.

1. Davies MJ, D’Alessio DA, Fradkin J, et al. Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2018;41:2669–701.

2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;1998(352):837–53.

3. Associazione Medici Diabetologi–Società Italiana di Diabetologia (AMD-SID). Standard italiani per la cura del diabete mellito 2016 [Italian standards for treatment of diabetes mellitus" 2016]. www.standarditaliani.it. Accessed May 2019.

4. International Diabetes Foundation (IDF). IDF clinical practice recommendations for managing type 2 diabetes in primary care. https://www.idf.org/our-activities/care-prevention/type-2-diabetes.html. Accessed 20 Oct 2019.

5. Associazione Medici Diabetologi–Società Italiana di Diabetologia (AMD-SID). Standard italiani per la cura del diabete mellito 2016 [Italian standards for treatment of diabetes mellitus" 2018]. www.standarditaliani.it. Accessed 2 May 2019.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Are the cardiovascular properties of GLP-1 receptor agonists differentially modulated by sulfonylureas? Insights from post-hoc analysis of EXSCEL;Diabetes Research and Clinical Practice;2024-06

2. Loureirin B promotes insulin secretion through GLP-1R and AKT/PDX1 pathways;European Journal of Pharmacology;2022-12

3. Trends in Antidiabetic Drug Discovery: FDA Approved Drugs, New Drugs in Clinical Trials and Global Sales;Frontiers in Pharmacology;2022-01-19

4. Careful use to minimize adverse events of oral antidiabetic medications in the elderly;Expert Opinion on Pharmacotherapy;2021-04-13

5. Clinical Effectiveness and Safety of Once-Weekly GLP-1 Receptor Agonist Dulaglutide as Add-On to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes;Journal of Clinical Medicine;2021-03-02